Global X Financial Statements From 2010 to 2024
| EDOC Etf | USD 10.48 0.16 1.55% |
Check Global X financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Global X's main balance sheet or income statement drivers, such as , as well as many indicators such as . Global financial statements analysis is a perfect complement when working with Global X Valuation or Volatility modules.
Global |
Global X Telemedicine ETF Beta Analysis
Global X's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Global X Beta | 1.22 |
Most of Global X's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Global X Telemedicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Global X Telemedicine has a Beta of 1.22. This is much higher than that of the Global X Funds family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.
About Global X Financial Statements
Global X stakeholders use historical fundamental indicators, such as Global X's revenue or net income, to determine how well the company is positioned to perform in the future. Although Global X investors may analyze each financial statement separately, they are all interrelated. For example, changes in Global X's assets and liabilities are reflected in the revenues and expenses on Global X's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Global X Telemedicine. Please read more on our technical analysis and fundamental analysis pages.
The index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of telemedicine and digital health, as well as applications thereof , as defined by Solactive AG, the provider of the index. Gx Telemedicine is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global X Telemedicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Global X's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Global X Telemedicine Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Global X Telemedicine Etf:Check out the analysis of Global X Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
The market value of Global X Telemedicine is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global X's value that differs from its market value or its book value, called intrinsic value, which is Global X's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global X's market value can be influenced by many factors that don't directly affect Global X's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global X's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global X is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global X's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.